July 1, 2009

July 1, 2010

This activity has been designed to meet the educational needs of pediatricians, immunologists and primary care physicians treating children and ancillary pediatric healthcare professionals.

Despite the availability of safe, effective vaccines, many pediatric diseases still cause morbidity and drain healthcare resources in the United States and worldwide. In this program, infectious disease experts discuss hepatitis A, meningococcal disease, pneumococcal disease, rotavirus, and human papillomavirus vaccine development and implementation and how they have affected disease epidemiology in the United States and one representative country each. A presentation on hot topics in vaccine safety is also included. The program concludes with a roundtable discussion in which the faculty present their viewpoints on issues related to vaccine-preventable diseases in the United States and worldwide.

After completing this activity, participants should be better able to:

• Explain the clinical syndromes and epidemiology of hepatitis A, invasive meningococcal disease, pneumococcal disease, rotavirus, and HPV, respectively.
• Differentiate the mechanisms of transmission and identify high-risk individuals for hepatitis A, menigococcal disease, pneumococcal disease, rotavirus, and HPV.
• Compare the epidemiology between the United States and one other country for each disease.
• Determine effective prevention strategies against hepatitis A, meningococcal disease, pneumococcal disease, rotavirus, and HPV.
• Illustrate how a global strategy for disease prevention integrates with the US approach.
• Determine 2 safety issues that have the potential to impede pediatric strategies for ensuring patient safety.

Steven Black, MD
Professor of Pediatrics and Infectious Disease
Center for Global Health
Cincinnati Children’s Hospital
Cincinnati, OH

Ron Dagan, MD
Professor
Faculty of Health Sciences
Ben Gurion University
Director, Pediatric Infectious Disease Unit
Soroka University Medical Center
Beer-Sheva, Israel

Shabir A. Madhi, MD, PhD
Professor of Vaccinology
Co-director Respiratory and Meningeal Pathogens Research Unit
& Chair: DST/NRF: Vaccine Preventable Diseases
University of Witwatersrand
Johannesburg, South Africa

Colin Marchant, MD
Associate Professor, Pediatrics
Boston University and Tufts University
Director, Center for Pediatric Vaccine Research
Pediatric Infectious Disease
Boston Medical Center – Tufts Medical Center
Boston, MA

Stephen Pelton, MD
Course Director
Professor of Pediatrics
Boston University School of Medicine
Chief, Section of Pediatric Infectious Diseases
Boston Medical Center
Boston, MA

Mathuram Santosham, MD, MPH
Professor, Department of International Health and Pediatrics
Director, Health Systems Program
Director, Center for American Indian Health
Johns Hopkins University
Baltimore, MD

This activity has been planned and implemented in accordance with Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Boston University School of Medicine and Med Learning Group. Boston University School of Medicine is accredited by the Accreditation Council to provide continuing medical education for physicians.

E.GLOBALMLG09

Boston University School of Medicine designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

There are no fees for participating and receiving CME credit for this activity. During the period July 1, 2009 through July 1, 2010, participants must:

1. Read the educational objectives and faculty disclosures
2. Study all parts of the educational activity
3. Complete the posttest by recording the best answer to each question in the answer key on the evaluation form
4. Submit the evaluation form online via iQueue

To participate in this activity, please view the presentation and take the posttest. Fill in the answer sheet and evaluation form and submit online via iQueue. CME credit will be awarded if a score of 70% or better is achieved. You will receive your certificate instantly.

Estimated time to complete: 2.0 hours.

For CME questions, please contact BUSM at 617-638-4605 or by email at cme@bu.edu.

BUSM's privacy policy: http://www.bu.edu/cme/policies/privacy_policy.html

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices is being discussed.

Steven Black, MD
Consultant: GlaxoSmithKline, Merck & Co., Inc., Novartis Pharmaceuticals
Speaker’s Bureau: sanofi pasteur

Ron Dagan, MD
Grant/Research Support: Binax, Inc., Crucell/Berna, GlaxoSmithKline, MedImmune, Merck & Co., Inc., Novartis Pharmaceuticals, and Wyeth Pharmaceuticals
Consultant: Crucell/Berna, GlaxoSmithKline, MedImmune, Inc., Merck & Co. Inc., Novartis Pharmaceuticals, and Wyeth Pharmaceuticals
Speaker’s Bureau: Crucell/Berna, GlaxoSmithKline, and Wyeth Pharmaceuticals

Shabir Ahmed Madhi, MBBCh, FCPaeds (SA), PhD
Grant/Research Support: GlaxoSmithKline and Wyeth Pharmaceuticals
Speaker’s Bureau: GlaxoSmithKline and Wyeth Pharmaceuticals
Advisory Board: Merck & Co., Inc.

Colin Marchant, MD
Grant/Research Support: GlaxoSmithKline, Merck & Co., Inc., Novartis Pharmaceuticals, and Wyeth Pharmaceuticals
Consultant: GlaxoSmithKline, Merck & Co., Inc., and Novartis Pharmaceuticals

Stephen Pelton, MD
Grant/Research Support: GlaxoSmithKline and Wyeth Pharmaceuticals
Consultant: GlaxoSmithKline, Novartis Pharmaceuticals, and Wyeth Pharmaceuticals
Speaker’s Bureau: MedImmune, Inc., and sanofi pasteur

Mathuram Santosham, MD, MPH
Has nothing to disclose.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Tara Hun-Dorris, MMC, ELS
Consultant: Victory Pharma, Inc.

Elizabeth Gifford of Boston University School of Medicine and Jason Worchester of Boston Medical Center have nothing to disclose.

Christopher J. Cahill of Med Learning Group has nothing to disclose.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTHCARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKE NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.